Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel

Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel

Abstract Chimeric antigen receptor (CAR) T cell–related HLH/MAS is an unusual manifestation of severe cytokine release syndrome (CRS) with poor prognosis and a challenging diagnosis. The establishment of specific diagnosis criteria is essential, and the combination of several techniques for CAR T‐ce...

Full description

Bibliographic Details
Main Authors: Reyes Maria Martín‐Rojas, Ignacio Gómez‐Centurión, Rebeca Bailén, Mariana Bastos, Francisco Diaz‐Crespo, Diego Carbonell, Rafael Correa‐Rocha, Marjorie Pion, Cristina Muñoz, Milagros Sancho, Isabel Gómez Fernández, Gillen Oarbeascoa, Ana Pérez‐Corral, Carolina Martínez‐Laperche, Javier Anguita, Ismael Buño, Javier Menárguez, Jose Luis Díez‐Martín, Mi Kwon
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Clinical Case Reports
Subjects:
CAR T cells
hemophagocytic lymphohistiocytosis
macrophage activation syndrome
tisagenlecleucel
Online Access:https://doi.org/10.1002/ccr3.5209

Internet

https://doi.org/10.1002/ccr3.5209

Similar Items